Personal Genome Diagnostics Company Profile: Acquisition & Investors

Personal Genome Diagnostics Overview

Founded
2010

Status
Acquired/Merged

Employees
135

Latest Deal Type
M&A

Latest Deal Amount
$575M

Investors
21

Personal Genome Diagnostics General Information

Description

Developer of cancer genome testing products designed to empower the fight against cancer by unlocking actionable information from the genome. The company's technologies and bioinformatics help in identifying tumor mutations with accuracy by identifying alterations in complex cancer genomes, enabling oncology researchers, drug developers, clinicians, and patients to address cancer-related genetic changes.

Contact Information

Website

www.personalgenome.com

Ownership Status

Acquired/Merged
(Operating Subsidiary)

Financing Status

Formerly VC-backed

Primary Industry

Discovery Tools (Healthcare)

Other Industries

Biotechnology

Parent Company

Laboratory Corporation of America

Primary Office

3600 Boston Street
Suite 10
Baltimore, MD 21224
United States

+1 (855) 000-0000





Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Personal Genome Diagnostics Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Post-Val	Status	Stage
15. Merger/Acquisition	21-Feb-2022	$575M	00000	00000	Completed	Generating Revenue
14. Later Stage VC (Series C)	10-Feb-2021	00000	00000	00000	Completed	Generating Revenue
13. Later Stage VC (Series 1)	24-Jul-2020	00.000	00000	000.00	Completed	Generating Revenue
12. Debt - PPP	27-Apr-2020	00.000	00000		Completed	Generating Revenue
11. Later Stage VC (Series B)	04-Jan-2018	0000	00000	00000	Completed	Generating Revenue
10. Grant	01-Jan-2017	00000	000.00		Completed	Generating Revenue
9. Debt - General	05-Jan-2016		000.00		Completed	Generating Revenue
8. Later Stage VC (Series A)	28-Oct-2015	000.00	000.00	000.00	Completed	Generating Revenue
7. Debt - General	27-Jul-2015		$3.3M		Completed	Generating Revenue
6. Seed Round	02-Apr-2014	$2.8M	$3.3M		Completed	Startup

To view Personal Genome Diagnostics’s complete valuation and funding history, request access »

Personal Genome Diagnostics Cap Table

Stock	# of Shares Authorized	Par Value	Dividend Rate (%)	Original Issue Price	Liquidation	Liquidation Pref. Multiple	Conversion Price	% Owned
Series C	000,000,000	00.000000	00	00.00	00.00	00	00.00	00.000
Series 1	0,000,000	00.000000		00.00	00.00	00	00.00	0.000
Series B	17,648,295	$0.001000		$3.13	$3.13	1x	$3.13	2.07%
Series A	14,322,061	$0.001000		$1.48	$1.48	1x	$1.48	1.68%

To view Personal Genome Diagnostics’s complete cap table history, request access »

Personal Genome Diagnostics Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Developer of cancer genome testing products designed to empower the fight against cancer by unlocking actionable informa

Discovery Tools (Healthcare)

Baltimore, MD

135 As of 2021

00000

0000 0000-00-00

000000&0 00000

000000 0

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e

0000000000000

Salt Lake City, UT

0000 As of 0000

00000

000000 - 000 00000

00000 00

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali

0000000000000

Irving, TX

0000 As of 0000

00.00

0.000 0000-00-00

0000000 0000 00.00

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Personal Genome Diagnostics Competitors (47)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Myriad Genetics	Corporation	Salt Lake City, UT	0000	00000	000000 - 000	00000
00000 0000 0000000	Private Equity-Backed	Irving, TX	0000	00.00	0000000 0000	00.00
00000000	Private Equity-Backed	Holliston, MA	00	000.00	000000000 -	000.00
0000 (000000000000	Venture Capital-Backed	Philadelphia, PA	00	000.00	00000000000	000.00
0000000000	Venture Capital-Backed	Cambridge, United Kingdom	00	000.00	0000000000 0	000.00

You’re viewing 5 of 47 competitors. Get the full list »

Personal Genome Diagnostics Patents

44
Total Documents Applications and Grants
000
Total Patents Families
2
Granted
6
Pending
000
Expiring in next 12 mo

Personal Genome Diagnostics Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)
AU-2020262082-A1	Methods and systems for genetic analysis	Pending	22-Apr-2019	000000000
CA-3137130-A1	Methods and systems for genetic analysis	Pending	22-Apr-2019	000000000
AU-2020205609-A1	Quantification of sequencing instruments and reagents for use in molecular diagnostic methods	Pending	07-Jan-2019	000000000
CA-3125530-A1	Quantification of sequencing instruments and reagents for use in molecular diagnostic methods	Pending	07-Jan-2019	000000000
US-20200219594-A1	Quantification of sequencing instruments and reagents for use in molecular diagnostic methods	Pending	07-Jan-2019	G16H40/40

To view Personal Genome Diagnostics’s complete patent history, request access »

Personal Genome Diagnostics Executive Team (21)

Name	Title	Board Seat	Contact Info
Megan Bailey	Chief Executive Officer
Brent Dial	Chief Financial Officer
Jamie Platt Ph.D	Chief Operating Officer
Samuel Angiuoli Ph.D	Chief Information Officer
Ana Bacchus	Controller

You’re viewing 5 of 21 executive team members. Get the full list »

Personal Genome Diagnostics Board Members (12)

Name	Representing	Role
Adam Fine	Windham Venture Partners	Board Observer
Felix Dawson	Personal Genome Diagnostics	Board Observer
James LaFrance	Personal Genome Diagnostics	Board Member
Justin Klein MD	New Enterprise Associates	Board Member
Kavita Patel MD	New Enterprise Associates	Board Member